The Role of Artificial Intelligence in Heart Failure Diagnostics, Risk Prediction, and Therapeutic Strategies: A Comprehensive Review.

Heart failure (HF) is a prevalent global health concern, impacting millions and contributing to high morbidity, mortality, and healthcare costs. The management of HF involves complex strategies, and traditional approaches often fail to address the escalating burden of hospital readmissions and deteriorating patient quality of life. Artificial intelligence (AI) has emerged as a promising tool for enhancing diagnostic accuracy, personalizing treatment plans, and improving patient outcomes in HF care. This narrative review investigates how AI technologies can benefit HF patients' quality of life by improving risk assessment, patient self-management, and diagnostics. A comprehensive review of the literature was conducted through the studies on PubMed, Scopus, and Embase, primarily focusing on AI applications in HF diagnosis, management, and patient education, with key studies selected to highlight the role of AI in improving clinical outcomes and reducing hospital readmissions. AI-driven tools, such as neural networks and deep learning algorithms, have demonstrated high accuracy in the early detection of HF, enabling timely interventions that mitigate disease progression. Rule-based AI systems apply fixed clinical rules to standardize HF diagnostics but cannot adjust to individual patient differences. Machine learning methods analyze structured health records to forecast risks like hospitalizations or refine treatments. Deep learning techniques, using neural networks, detect subtle heart abnormalities in complex imaging data like echocardiograms that conventional approaches might overlook. Personalized digital health applications, including avatar-based self-management programs, have significantly improved quality of life by empowering patients to monitor symptoms, adhere to treatment regimens, and engage proactively in their care. Furthermore, AI's integration into cardiac imaging systems enhances precision in identifying subtle cardiac abnormalities. At the same time, remote monitoring technologies leverage predictive analytics to flag decompensation risks, allowing clinicians to adjust therapies preemptively. These advancements collectively optimize therapeutic strategies and reduce rehospitalization rates. Despite challenges such as implementation costs, data privacy concerns, and ethical considerations surrounding algorithmic bias, AI's evolving role in HF management highlights its transformative potential. By bridging gaps in personalized care, fostering patient engagement, and refining risk stratification, AI promises to revolutionize HF management paradigms, shifting the focus from reactive treatment to proactive, patient-centered precision medicine. This integration addresses systemic inefficiencies and holds promise for sustainable improvements in long-term outcomes and quality of life for HF patients globally.